| Reactions | Indication | | ROR (95% CI) | PRR (95% CI, ) | BCPNN (IC-2SD) | EBGM (EBGM05) |
| Melaena | Thrombosis prophylaxis | 127 | 1.95 (1.64, 2.33) | 1.95 (1.78, 2.13, 57.64) | 0.95 (0.93) | 1.95 (1.8) | Duodenal ulcer | Thrombosis prophylaxis | 31 | 1.48 (1.04, 2.1) | 1.48 (1.12, 1.83, 4.26) | 0.54 (0.5) | 1.47 (1.18) | Microcytic anemia | Thrombosis prophylaxis | 25 | 3.59 (2.42, 5.32) | 3.58 (3.19, 3.98, 43.51) | 1.69 (1.63) | 3.55 (3.22) | Lip erosion | Thrombosis prophylaxis | 22 | 3.85 (2.53, 5.86) | 3.85 (3.42, 4.27, 42.94) | 1.76 (1.69) | 3.81 (3.46) | Vascular stent thrombosis | Thrombosis prophylaxis | 22 | 3.99 (2.62, 6.07) | 3.99 (3.57, 4.41, 45.67) | 1.81 (1.73) | 3.95 (3.6) | Mucosal erosion | Thrombosis prophylaxis | 21 | 3.86 (2.51, 5.94) | 3.86 (3.43, 4.29, 41.12) | 1.76 (1.69) | 3.82 (3.46) | Nikolsky’s sign | Thrombosis prophylaxis | 18 | 4.02 (2.53, 6.41) | 4.02 (3.56, 4.49, 37.42) | 1.78 (1.7) | 3.98 (3.59) | Hematoma muscle | Thrombosis prophylaxis | 16 | 8.02 (4.88, 13.17) | 8.02 (7.52, 8.51, 88.91) | 2.48 (2.36) | 7.83 (7.41) | Vascular stent stenosis | Thrombosis prophylaxis | 8 | 3.58 (1.78, 7.19) | 3.58 (2.88, 4.28, 12.25) | 1.47 (1.35) | 3.55 (2.97) | Thalamus hemorrhage | Thrombosis prophylaxis | 8 | 3.13 (1.56, 6.28) | 3.13 (2.43, 3.83, 9.46) | 1.33 (1.23) | 3.11 (2.53) | Total | | 298 | | | | |
|
|